Medicare to crack down on PBM 'lock-in'

The federal agency that manages Medicare said Tuesday it had finalized a rule meant to curb an industry practice that has inflated drug costs for some patients with Medicare drug coverage. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.